NLRP3 and breast cancer: Additional reports have described roles for microRNA-22 (miR-22), miR-135a, and miR-233 in negatively regulating NLRP3 expression while suppressing the progression of an oral squamous cell carcinoma model, a pancreatic cancer model, and a breast cancer model, respectively [36,37,38].